📊 CGC Key Takeaways
Is Canopy Growth Corp (CGC) a Good Investment?
Insufficient financial data available for fundamental analysis. With only 2 metrics available and most key financial indicators marked as N/A, a meaningful assessment of profitability trends, financial health, and growth quality cannot be performed. Data quality and availability severely limit analytical capability.
Canopy Growth’s fundamentals are improving, with Q3 FY2026 net loss narrowing 49% year over year, free cash outflow improving, and leverage easing as debt falls against a much larger cash balance. However, the business is still structurally unprofitable, revenue is roughly flat, margins remain pressured, and liquidity improvement has depended heavily on external financing and share issuance rather than internally generated cash.
Why Buy Canopy Growth Corp Stock? CGC Key Strengths
- Recent insider activity with 3 Form 4 filings in last 90 days suggests management engagement
- Listed on Nasdaq indicating established public company status
- Operates in medicinal chemicals sector with potential long-term market demand
- Balance sheet liquidity improved materially, with cash and cash equivalents of C$371 million at December 31, 2025 and total liabilities down versus March 31, 2025.
- Operating performance is stabilizing, with stronger Canada medical and adult-use cannabis sales and a third straight quarter of adjusted EBITDA improvement.
- Debt burden has been reduced and refinancing actions extended maturities, lowering near-term balance sheet stress.
CGC Stock Risks: Canopy Growth Corp Investment Risks
- Critical data unavailability - revenue, net income, and profitability metrics are all N/A
- Complete absence of balance sheet detail prevents assessment of financial stability and leverage
- No cash flow data available to evaluate operational efficiency or capital allocation
- Extremely limited metrics (only 2 of numerous standard metrics) prevents fundamental analysis
- Data freshness date of 2025-12-31 is future-dated, indicating potential data integrity issues
- The company remains loss-making, with Q3 FY2026 operating loss of C$26 million and net loss of C$63 million, so profitability is still not proven.
- Cash generation is weak: operations used cash and free cash flow remained negative, meaning the turnaround is not yet self-funding.
- Growth quality is mixed because revenue is flat overall and the capital structure has been heavily diluted, with common shares outstanding rising sharply.
Key Metrics to Watch
- Revenue and revenue growth trends
- Gross profit margin and operating margin
- Operating cash flow and free cash flow
- Total debt and debt-to-equity ratio
- Net income and earnings quality
- Sustainable positive adjusted EBITDA and free cash flow from operations without reliance on equity financing
- Net revenue growth and gross margin in Canada cannabis and international medical markets
Canopy Growth Corp (CGC) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CGC Profit Margin, ROE & Profitability Analysis
CGC vs Materials Sector: How Canopy Growth Corp Compares
How Canopy Growth Corp compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Canopy Growth Corp Stock Overvalued? CGC Valuation Analysis 2026
Based on fundamental analysis, Canopy Growth Corp has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Canopy Growth Corp Balance Sheet: CGC Debt, Cash & Liquidity
CGC Revenue Growth, EPS Growth & YoY Performance
CGC SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Canopy Growth Corp (CIK: 0001737927)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CGC
What is the AI rating for CGC?
Canopy Growth Corp (CGC) has a Combined AI Rating of SELL from Claude (HOLD) and ChatGPT (SELL) with 49% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are CGC's key strengths?
Claude: Recent insider activity with 3 Form 4 filings in last 90 days suggests management engagement. Listed on Nasdaq indicating established public company status. ChatGPT: Balance sheet liquidity improved materially, with cash and cash equivalents of C$371 million at December 31, 2025 and total liabilities down versus March 31, 2025.. Operating performance is stabilizing, with stronger Canada medical and adult-use cannabis sales and a third straight quarter of adjusted EBITDA improvement..
What are the risks of investing in CGC?
Claude: Critical data unavailability - revenue, net income, and profitability metrics are all N/A. Complete absence of balance sheet detail prevents assessment of financial stability and leverage. ChatGPT: The company remains loss-making, with Q3 FY2026 operating loss of C$26 million and net loss of C$63 million, so profitability is still not proven.. Cash generation is weak: operations used cash and free cash flow remained negative, meaning the turnaround is not yet self-funding..
What is CGC's revenue and growth?
Canopy Growth Corp reported revenue of N/A.
Does CGC pay dividends?
Canopy Growth Corp does not currently pay dividends.
Where can I find CGC SEC filings?
Official SEC filings for Canopy Growth Corp (CIK: 0001737927) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CGC's EPS?
Canopy Growth Corp has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is CGC a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Canopy Growth Corp has a SELL rating with 49% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is CGC stock overvalued or undervalued?
Valuation metrics for CGC: ROE of N/A (sector avg: 14%), net margin of N/A (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy CGC stock in 2026?
Our dual AI analysis gives Canopy Growth Corp a combined SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is CGC's free cash flow?
Canopy Growth Corp's operating cash flow is N/A, with capital expenditures of N/A.
How does CGC compare to other Materials stocks?
Vs Materials sector averages: Net margin N/A (avg: 10%), ROE N/A (avg: 14%), current ratio N/A (avg: 1.6).